Discovery of a mechanism that regulates cell movementJuly 21, 2008In Nature Cell Biology, researchers at IRB Barcelona describe a mechanism that governs adhesion between cells and therefore their capacity to move A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion. This same mechanism may be defective in diseases such as cancer and its metastasis, when tumour cells lose their adhesion to neighbouring cells and migrate through the organism. The results of this research have been published in this week's Nature Cell Biology. Specialists in development, Daniel Shaye, Jordi Casanova and Marta Llimargas, have studied the mechanisms that control cell movements during trachea development in the fly Drosophila. In this process, cells that initially form column of two cells deep, change their position to line up one after the other in a single file. A key element in the regulation of these movements is the amount of adhesive protein E-Cadherin located in the cellular membrane. Jordi Casanova, head of the Morphogenesis in Drosophila at IRB Barcelona, explains that "when movement starts, the levels of this protein in the cells decrease, thereby allowing them to slide one on top of the other, and once in this position the levels of this protein are re-established in order to seal the new binding alignment". The in-depth study of this phenomenon has led to the finding that the amount of E-Cadherin on the cell surface is controlled by the trafficking of this protein inside the cell and the identification of the elements that regulate this transport. During the experiments, the researchers induced or blocked cell movement by modifying the elements that control the trafficking of adhesive protein towards the membrane. "We demonstrate a mechanism that explains how cells can change their position within a given tissue. The sequence is clear: the greater the amount of protein, the greater the adhesion and the smaller the movement", recaps Casanova.
A mechanism may be dysfunctional during cancer progression and metastases The role of E-Cadherin in the binding between epithelial cells is universal in all animals and therefore, following logic, the researchers believe that the mechanisms that regulate the levels of this protein may also be universal. "We speculate that the regulatory mechanism that we have discovered may also be present in other developmental contexts. However, in addition, fundamental elements of the mechanism may show a dysfunction in pathological processes such as the progression of cancer and metastases", adds Casanova. As revealed by this same researcher, the amounts of E-Cadherin and of one of the elements required for trafficking decrease in the progression of a kind of oesophagus cancer and this effect is related to the gain in tumour cell motility, which allows them to spread throughout the body more rapidly. Thanks to this study, researchers working on cancer will be able to use animal models to test whether this mechanism is defective in other kinds of tumours and to study whether any of its genetic components are valid as therapeutic targets. Institute for Research in Biomedicine (IRB Barcelona) | |||||||||||||||||||||
|
Related Cell Movement News Articles New stem cell technique improves genetic alteration UC Irvine researchers have discovered a dramatically improved method for genetically manipulating human embryonic stem cells, making it easier for scientists to study and potentially treat thousands of disorders ranging from Huntington's disease to muscular dystrophy and diabetes. Scripps research scientists find new genetic mutation that halts the development of lupus The lupus-suppressing action is the result of what is known as a nonsense mutation of the Coronin-1A gene (Coro1a) required for the development of the disease. Breast cancer cells have to learn to walk before they can run Early-stage breast cancer that has not yet invaded the surrounding tissues may already contain highly motile cells, bringing the tumor one step closer to metastasis, report researchers at the Salk Institute for Biological Studies. 'Muscle' protein drives prostate cancer Researchers at the Johns Hopkins Kimmel Cancer Center have for the first time implicated the muscle protein myosin VI in the development of prostate cancer and its spread. Two-faced protein can stop metastasis or promote it, researchers say A protein known to be a key component of the glue that holds cells together also is involved in breaking them apart and promoting their movement when tumors begin to spread to other parts of the body, researchers at Mayo Clinic have found. Jefferson scientists show protein key to bladder cancer spread, potential drug target By demonstrating that a protein - a growth factor called proepithelin - plays a crucial role in the spread of bladder cancer, scientists at Jefferson Medical College and Jefferson's Kimmel Cancer Center may have identified a potential target for drugs. Mayo Clinic researchers discover cancer cells may move via wave stimulation Mayo Clinic researchers have uncovered a new cellular secret that may explain how certain cancers move and spread - a feature of cancers that makes treatment especially difficult. A new focus for the mechanism of nerve growth Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in the March issue of Nature Cell Biology. Discoveries may advance stem cell therapy for Parkinson's, cancer patients Two studies in the Jan. 27, 2006 Cell have yielded evidence that could prove a boon for stem cell therapies aimed at patients with Parkinson's disease and those with compromised immune systems due to intensive cancer therapy or autoimmune disease, according to researchers. Role of the nervous system in regulating stem cells discovered New study by Mount Sinai researchers may lead to improved stem cell therapies for patients with compromised immune systems due to intensive cancer therapy or autoimmune disease. More Cell Movement News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||